NO20041070L - Preparat for behandling av vanlig forkjolelse. - Google Patents

Preparat for behandling av vanlig forkjolelse.

Info

Publication number: NO20041070L
Authority: NO; Norway
Prior art keywords: preparation; treatment; salt; combination; common colds
Prior art date: 2001-09-18

Application number

NO20041070A

Other languages

English (en)

Other versions

NO334441B1 (no

Inventor

Hanne Anette Moesgaard

Karin Lowenstein Christensen

Original Assignee

Nycomed Danmark Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-18

Filing date

2004-03-12

Publication date

2004-05-18

2004-03-12 Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps

2004-05-18 Publication of NO20041070L publication Critical patent/NO20041070L/no

2014-03-03 Publication of NO334441B1 publication Critical patent/NO334441B1/no

Links

201000009240 nasopharyngitis Diseases 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
208000036071 Rhinorrhea Diseases 0.000 abstract 1
206010039101 Rhinorrhoea Diseases 0.000 abstract 1
239000000812 cholinergic antagonist Substances 0.000 abstract 1
OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
229960001888 ipratropium Drugs 0.000 abstract 1
210000002850 nasal mucosa Anatomy 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000005526 vasoconstrictor agent Substances 0.000 abstract 1
229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Polyurethanes Or Polyureas (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Cosmetics (AREA)

NO20041070A 2001-09-18 2004-03-12 Preparat for behandling av vanlig forkjølelse. NO334441B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101356		2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en)	2001-09-18	2002-09-18	Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (2)

Publication Number	Publication Date
NO20041070L true NO20041070L (no)	2004-05-18
NO334441B1 NO334441B1 (no)	2014-03-03

Family

ID=8160714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041070A NO334441B1 (no)	2001-09-18	2004-03-12	Preparat for behandling av vanlig forkjølelse.

Country Status (20)

Country	Link
US (2)	US7652030B2 (no)
EP (2)	EP1446119B1 (no)
JP (1)	JP4500045B2 (no)
KR (1)	KR100810872B1 (no)
CN (1)	CN1290502C (no)
AT (1)	ATE318601T1 (no)
BR (1)	BRPI0212586B8 (no)
CA (1)	CA2460140C (no)
DE (1)	DE60209511T2 (no)
DK (1)	DK1446119T3 (no)
EA (1)	EA008165B1 (no)
ES (1)	ES2259098T3 (no)
HU (1)	HU226527B1 (no)
MX (1)	MXPA04002500A (no)
NO (1)	NO334441B1 (no)
NZ (1)	NZ531792A (no)
PL (1)	PL208686B1 (no)
PT (1)	PT1446119E (no)
SI (1)	SI1446119T1 (no)
WO (1)	WO2003024433A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60209511T2 (de) *	2001-09-18	2006-10-05	Nycomed Danmark Aps	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
RU2006132043A (ru) *	2004-02-06	2008-03-20	МЕДА Фарма ГмбХ унд Ко.КГ (DE)	Комбинация и фармацевтический препарат для лечения ринита
WO2005084330A2 (en) *	2004-03-02	2005-09-15	Synergia Pharma, Inc.	Compositions and methods for treating nasal congestion
DE102004049008A1 (de) *	2004-10-05	2006-04-06	Merck Patent Gmbh	Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
MX2007007836A (es) *	2004-12-27	2007-08-20	Eisai R&D Man Co Ltd	Metodo para estabilizar un farmaco anti-demencia.
DE102006023770A1 (de) *	2006-05-20	2007-11-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) *	2008-04-25	2009-10-29	Kenneth Gould	Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de)	2009-03-31	2013-10-23	Boehringer Ingelheim International GmbH	Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja)	2009-05-18	2015-08-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	アダプタ、吸入器具及びアトマイザ
WO2011064163A1 (en)	2009-11-25	2011-06-03	Boehringer Ingelheim International Gmbh	Nebulizer
BR112012012475B1 (pt)	2009-11-25	2020-03-03	Boehringer Ingelheim International Gmbh	Nebulizador
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
WO2011160932A1 (en)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Nebulizer
EP2694220B1 (de)	2011-04-01	2020-05-06	Boehringer Ingelheim International GmbH	Medizinisches gerät mit behälter
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (de)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Zerstäuber mit kodiermitteln
WO2014158119A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş	Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş.	Suspension composition containing ipratropium and oxymetazoline
ES2836977T3 (es)	2013-08-09	2021-06-28	Boehringer Ingelheim Int	Nebulizador
JP6643231B2 (ja)	2013-08-09	2020-02-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
WO2015054359A1 (en) *	2013-10-08	2015-04-16	Ebadi Mark A	Methods and compositions for symptomatic reflief of the common cold
WO2015169430A1 (en)	2014-05-07	2015-11-12	Boehringer Ingelheim International Gmbh	Nebulizer
IL247927B (en)	2014-05-07	2022-09-01	Boehringer Ingelheim Int	Container, a device that turns a liquid into a fine spray and use
CN116036425A (zh)	2014-05-07	2023-05-02	勃林格殷格翰国际有限公司	喷雾器、指示器装置及容器
US20170348230A1 (en) *	2014-12-24	2017-12-07	Jadran-Galenski Laboratorij D.D	A nasal composition containing sea water as stability-improving excipient
MX383771B (es) *	2015-12-02	2025-03-14	Pablo Cortes Borrego	Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) *	2020-07-31	2022-02-03	Eye Therapies Llc	Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69229880T2 (de) *	1991-11-19	2000-05-04	The University Of Virginia Patent Foundation, Charlottesville	Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
IL101056A (en)	1992-02-24	1997-03-18	Res & Dev Co Ltd	Composition for nasal treatment
GB9218834D0 (en)	1992-09-05	1992-10-21	Procter & Gamble	Nasal spray products
ATE177941T1 (de) *	1992-12-09	1999-04-15	Boehringer Ingelheim Pharma	Stabilisierte medizinische aerosollösungen
EP0780127A1 (en)	1995-12-19	1997-06-25	The Procter & Gamble Company	A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de)	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
WO1998048839A1 (en) *	1997-04-30	1998-11-05	Warner-Lambert Company	Topical nasal antiinflammatory compositions
CA2311530C (en) *	1998-01-30	2008-06-10	Novartis Consumer Health S.A.	Nasal solutions
BR9911351A (pt)	1998-06-18	2001-03-13	Boehringer Ingelheim Pharma	Formulações farmacêuticas para aerossóis com duas ou mais substâncias ativas
AU765736B2 (en)	1999-06-22	2003-09-25	Boehringer Ingelheim International Gmbh	Stable xylometazoline and oxymetazoline solution
DE60209511T2 (de) *	2001-09-18	2006-10-05	Nycomed Danmark Aps	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

2002
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0212586B8 (pt)	2021-05-25
SI1446119T1 (sl)	2006-08-31
PT1446119E (pt)	2006-07-31
ATE318601T1 (de)	2006-03-15
JP4500045B2 (ja)	2010-07-14
EP1446119B1 (en)	2006-03-01
JP2005505569A (ja)	2005-02-24
EP1661570A2 (en)	2006-05-31
US8450339B2 (en)	2013-05-28
KR100810872B1 (ko)	2008-03-06
WO2003024433A3 (en)	2004-06-10
BR0212586B1 (pt)	2013-11-19
KR20040049849A (ko)	2004-06-12
EA008165B1 (ru)	2007-04-27
ES2259098T3 (es)	2006-09-16
HK1067984A1 (en)	2005-04-22
PL370536A1 (en)	2005-05-30
BR0212586A (pt)	2004-10-13
EP1661570A3 (en)	2012-10-24
MXPA04002500A (es)	2004-11-22
DE60209511T2 (de)	2006-10-05
HUP0402075A3 (en)	2008-04-28
CA2460140C (en)	2009-09-01
US7652030B2 (en)	2010-01-26
HUP0402075A2 (hu)	2005-02-28
PL208686B1 (pl)	2011-05-31
HU226527B1 (hu)	2009-03-30
US20100093783A1 (en)	2010-04-15
CN1555263A (zh)	2004-12-15
US20040248924A1 (en)	2004-12-09
DE60209511D1 (de)	2006-04-27
NO334441B1 (no)	2014-03-03
DK1446119T3 (da)	2006-07-10
WO2003024433A2 (en)	2003-03-27
CA2460140A1 (en)	2003-03-27
CN1290502C (zh)	2006-12-20
NZ531792A (en)	2006-02-24
EA200400444A1 (ru)	2005-02-24
EP1446119A2 (en)	2004-08-18

Legal Events

Date	Code	Title	Description
2006-05-02	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0
2016-02-22	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: TAKEDA PHARMA A/S, DK
2022-10-10	MK1K	Patent expired

Publication	Publication Date	Title
NO20041070L (no)	2004-05-18	Preparat for behandling av vanlig forkjolelse.
WO2003009838A1 (en)	2003-02-06	Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
WO2002070510A3 (de)	2003-01-30	Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
BR9812361A (pt)	2000-09-19	Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
WO2002085909A8 (en)	2004-04-29	9-deazaguanine derivatives as inhibitors of gsk-3
BR0313176A (pt)	2005-06-14	Composições de pirazol úteis como inibidores de gsk-3
CA2460865A1 (en)	2003-04-10	Quinoline derivatives as neuropeptide y antagonists
WO2006044362A3 (en)	2006-12-07	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
WO2002088100A3 (de)	2003-05-30	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
SG152257A1 (en)	2009-05-29	Topical preparation containing ambroxol
WO2003087049A3 (de)	2004-02-05	Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
BR0212329A (pt)	2004-09-21	Métodos para tratar doença pulmonar
SE0102440D0 (sv)	2001-07-05	New compound
CA2433833A1 (en)	2002-07-25	Use of flumazenil in developing a drug for the treatment of alcohol dependence
WO2002065989A3 (en)	2002-12-12	Aminoglycoside treatment for lysosomal storage diseases
CA2436511A1 (en)	2002-08-22	Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2005074983A3 (en)	2006-04-13	Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005039483A3 (en)	2005-09-29	Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
SE0000303D0 (sv)	2000-01-31	Novel compounds
PT1307192E (pt)	2006-06-30	Candesartan para tratamento da enxaqueca
BG105984A (bg)	2002-04-30	Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
WO2002069944A3 (de)	2003-10-02	Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
CA2436537A1 (en)	2002-05-10	Pharmaceutical compositions comprising tiotropium salts and antihistamines
WO2002069968A8 (en)	2003-04-17	New use